Akèy › Kansè poumon selil ti
Etid klinik pou Kansè poumon selil ti ap rekrite nan Etazini
97 etid pou Kansè poumon selil ti ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX26 etid
- Arlington, VA23 etid
- New York City, NY21 etid
- Boston, MA21 etid
- Nashville, TN20 etid
- Los Angeles, CA20 etid
- Orlando, FL15 etid
- St. Louis, MO13 etid
- Cleveland, OH13 etid
- Dallas, TX13 etid
- Detroit, MI12 etid
- Washington, DC12 etid
- Chicago, IL12 etid
- San Antonio, TX11 etid
- Baltimore, MD11 etid
- Seattle, WA10 etid
- Philadelphia, PA10 etid
- Omaha, NE9 etid
- Durham, NC9 etid
- Atlanta, GA9 etid
- Tampa, FL9 etid
- Grand Rapids, MI9 etid
- Indianapolis, IN9 etid
- Queens, NY9 etid
- Edison, NJ9 etid
- Aurora, CO8 etid
- Akron, OH8 etid
- Portland, OR8 etid
- Cedar Rapids, IA8 etid
- Miami, FL8 etid
- Cincinnati, OH7 etid
- Columbus, OH7 etid
- Austin, TX7 etid
- Louisville, KY7 etid
- Lexington, KY7 etid
- New Haven, CT7 etid
- West Valley City, UT7 etid
- Irving, TX6 etid
- Baldwin Park, CA6 etid
- Madison, WI6 etid
Pa eta
- Alabama10 etid
- Arizona9 etid
- Arkansas5 etid
- Colorado16 etid
- Connecticut9 etid
- Distrik Columbia5 etid
- Florid36 etid
- Georgia12 etid
- Illinois21 etid
- Indiana12 etid
- Iowa8 etid
- Kalifòni36 etid
- Kansas3 etid
- Kentucky15 etid
- Maryland19 etid
- Massachusetts22 etid
- Michigan26 etid
- Minnesota9 etid
- Missouri17 etid
- Nebraska11 etid
- New Jersey17 etid
- New Mexico3 etid
- New York31 etid
- North Carolina16 etid
- Ohio27 etid
- Oklahoma4 etid
- Oregon9 etid
- Pennsylvania15 etid
- South Carolina7 etid
- South Dakota3 etid
- Tennessee24 etid
- Texas41 etid
- Utah11 etid
- Virginia30 etid
- Washington13 etid
- Wisconsin11 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07189871Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 1, 2026 · NCT07509034A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06586957DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07472517Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07226999Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07476287A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07099898Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT02146170A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT03460977DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07365241A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07155174Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07278479Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Ap rekriteFaz 1
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT07006727A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT06066138A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07488676Study of Trilaciclib and Lurbinectidin
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05578326Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07730021BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07625644A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07459634Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT04342429A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07407933Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.